ArticleCancer immunology research2016

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers.

Ellen C Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.